$3.23 Billion is the total value of Nantahala Capital Management's 126 reported holdings in Q4 2020. The portfolio turnover from Q3 2020 to Q4 2020 was 44.7% .
Value | Shares | ↓ Weighting | ||||||
---|---|---|---|---|---|---|---|---|
IWM | Sell | ISHARES TRput | $597,983,000 | -11.3% | 3,050,000 | -32.2% | 18.53% | -10.1% |
W | WAYFAIR INCcall | $294,457,000 | -22.4% | 1,304,000 | 0.0% | 9.12% | -21.4% | |
SGMS | SCIENTIFIC GAMES CORPcall | $179,593,000 | +18.8% | 4,328,600 | 0.0% | 5.56% | +20.4% | |
CDXS | Sell | CODEXIS INC | $109,164,000 | +73.4% | 5,000,620 | -6.8% | 3.38% | +75.6% |
QADA | Buy | QAD INCcl a | $78,100,000 | +56.3% | 1,236,146 | +4.4% | 2.42% | +58.3% |
ESTA | Buy | ESTABLISHMENT LABS HLDGS INC | $76,865,000 | +116.1% | 2,042,099 | +6.4% | 2.38% | +118.9% |
DLB | Sell | DOLBY LABORATORIES INC | $74,872,000 | +20.3% | 770,845 | -17.9% | 2.32% | +21.9% |
VG | Buy | VONAGE HLDGS CORP | $69,279,000 | +30.6% | 5,380,865 | +3.8% | 2.15% | +32.4% |
QURE | Buy | UNIQURE NV | $59,128,000 | +1.4% | 1,636,539 | +3.4% | 1.83% | +2.7% |
CASH | Sell | META FINL GROUP INC | $56,326,000 | +62.8% | 1,540,646 | -14.4% | 1.74% | +64.9% |
SBTX | New | SILVERBACK THERAPEUTICS INC | $54,384,000 | – | 1,206,471 | +100.0% | 1.68% | – |
VAC | Sell | MARRIOTT VACTINS WORLDWID CO | $52,828,000 | +10.2% | 384,987 | -27.0% | 1.64% | +11.7% |
WYND | Sell | WYNDHAM DESTINATIONS INC | $50,126,000 | +24.9% | 1,117,394 | -14.3% | 1.55% | +26.6% |
CVNA | Sell | CARVANA COcall | $48,794,000 | -78.9% | 203,700 | -80.3% | 1.51% | -78.6% |
THC | Sell | TENET HEALTHCARE CORPcall | $47,721,000 | -19.0% | 1,195,100 | -50.3% | 1.48% | -17.9% |
TA | Sell | TRAVELCENTERS OF AMERICA INC | $42,087,000 | +65.8% | 1,291,003 | -0.6% | 1.30% | +68.0% |
GDEN | Sell | GOLDEN ENTMT INC | $40,400,000 | +37.3% | 2,031,172 | -4.5% | 1.25% | +39.1% |
QURE | Buy | UNIQURE NVcall | $40,196,000 | +2.7% | 1,112,500 | +4.7% | 1.24% | +4.0% |
SNDX | Buy | SYNDAX PHARMACEUTICALS INC | $39,998,000 | +102.4% | 1,798,453 | +34.3% | 1.24% | +105.1% |
LXFR | Buy | LUXFER HOLDINGS PLC | $38,493,000 | +34.7% | 2,344,245 | +2.9% | 1.19% | +36.5% |
KROS | Buy | KEROS THERAPEUTICS INC | $37,705,000 | +253.1% | 534,514 | +93.1% | 1.17% | +257.2% |
TBBK | Buy | BANCORP INC DEL | $37,619,000 | +65.9% | 2,755,982 | +5.0% | 1.17% | +68.3% |
DXPE | Buy | DXP ENTERPRISES INC | $34,082,000 | +40.8% | 1,533,170 | +2.2% | 1.06% | +42.7% |
IMXI | Sell | INTERNATIONAL MNY EXPRESS IN | $33,121,000 | -0.6% | 2,134,092 | -8.0% | 1.03% | +0.7% |
Buy | APTOSE BIOSCIENCES INC | $31,854,000 | -22.9% | 7,272,673 | +5.6% | 0.99% | -21.9% | |
CUE | Buy | CUE BIOPHARMA INC | $31,360,000 | -11.0% | 2,506,772 | +7.0% | 0.97% | -9.8% |
SFT | New | SHIFT TECHNOLOGIES INCcl a | $31,330,000 | – | 3,788,396 | +100.0% | 0.97% | – |
IMAX | New | IMAX CORP | $29,161,000 | – | 1,618,281 | +100.0% | 0.90% | – |
FBIO | Buy | FORTRESS BIOTECH INC | $27,518,000 | -17.2% | 8,680,909 | +5.5% | 0.85% | -16.0% |
IMTX | Sell | IMMATICS N.V | $27,131,000 | +0.6% | 2,514,489 | -4.1% | 0.84% | +1.9% |
FCFS | Sell | FIRSTCASH INC | $27,119,000 | +9.8% | 387,189 | -10.3% | 0.84% | +11.3% |
WVE | Buy | WAVE LIFE SCIENCES LTD | $26,422,000 | +30.8% | 3,357,305 | +41.2% | 0.82% | +32.5% |
INAQ | New | INSU ACQUISITION CORP II | $26,405,000 | – | 1,698,075 | +100.0% | 0.82% | – |
ALTG | Buy | ALTA EQUIPMENT GROUP INC | $25,688,000 | +34.2% | 2,600,012 | +6.3% | 0.80% | +35.8% |
TFFP | Sell | TFF PHARMACEUTICALS INC | $25,253,000 | -32.7% | 1,763,476 | -13.3% | 0.78% | -31.9% |
HCA | HCA HEALTHCARE INCput | $24,669,000 | +31.9% | 150,000 | 0.0% | 0.76% | +33.6% | |
CAR | AVIS BUDGET GROUPcall | $24,532,000 | +41.7% | 657,700 | 0.0% | 0.76% | +43.7% | |
UPLD | Buy | UPLAND SOFTWARE INC | $22,995,000 | +27.5% | 501,100 | +4.7% | 0.71% | +29.0% |
THC | Sell | TENET HEALTHCARE CORP | $22,547,000 | +17.6% | 564,659 | -27.8% | 0.70% | +19.3% |
BDSI | Buy | BIODELIVERY SCIENCES INTL IN | $21,519,000 | +13.9% | 5,123,671 | +1.1% | 0.67% | +15.4% |
EHTH | Buy | EHEALTH INC | $21,164,000 | +37.4% | 299,734 | +53.7% | 0.66% | +39.3% |
EXAS | EXACT SCIENCES CORPput | $19,874,000 | +30.0% | 150,000 | 0.0% | 0.62% | +31.6% | |
AKBA | Buy | AKEBIA THERAPEUTICS INC | $19,713,000 | +36.7% | 7,040,487 | +22.5% | 0.61% | +38.5% |
EVRI | Sell | EVERI HLDGS INC | $18,834,000 | +48.1% | 1,363,786 | -11.5% | 0.58% | +50.1% |
JYNT | Sell | JOINT CORP | $18,203,000 | +23.3% | 693,172 | -18.3% | 0.56% | +24.8% |
Buy | AKUMIN INC | $17,412,000 | -5.7% | 5,784,556 | +1.8% | 0.54% | -4.4% | |
CERC | Buy | CERECOR INC | $16,456,000 | +24.9% | 6,233,316 | +7.6% | 0.51% | +26.6% |
CRHM | Buy | CRH MED CORP | $16,119,000 | +9.9% | 6,892,005 | +1.7% | 0.50% | +11.1% |
AGLE | Sell | AEGLEA BIOTHERAPEUTICS INC | $15,538,000 | -29.8% | 1,974,302 | -36.8% | 0.48% | -29.0% |
VMD | Buy | VIEMED HEALTHCARE INC | $15,232,000 | +17.3% | 1,951,480 | +30.3% | 0.47% | +18.9% |
SLNO | Buy | SOLENO THERAPEUTICS INC | $15,192,000 | -18.5% | 7,871,356 | +6.0% | 0.47% | -17.4% |
PAYA | New | PAYA HOLDINGS INC | $14,811,000 | – | 1,100,000 | +100.0% | 0.46% | – |
FTIVU | Sell | FINTECH ACQUISITION CORP IVunit 12/31/2025 | $14,316,000 | +4.5% | 1,200,000 | -38.5% | 0.44% | +6.0% |
SIC | Sell | SELECT INTERIOR CONCEPTS INCcl a | $13,599,000 | -4.2% | 1,901,943 | -7.5% | 0.42% | -3.0% |
ZVO | Sell | ZOVIO INC | $13,468,000 | +18.0% | 2,841,286 | -0.4% | 0.42% | +19.5% |
CRIS | New | CURIS INC | $13,374,000 | – | 1,632,915 | +100.0% | 0.41% | – |
PAR | Sell | PAR TECHNOLOGY CORP | $12,703,000 | -12.1% | 202,312 | -43.3% | 0.39% | -10.9% |
PLCE | New | CHILDRENS PL INC | $12,649,000 | – | 252,472 | +100.0% | 0.39% | – |
CBIO | Buy | CATALYST BIOSCIENCES INC | $11,770,000 | +50.2% | 1,865,334 | +2.4% | 0.36% | +52.1% |
CERE | New | CEREVEL THERAPEUTICS HLDNG I | $11,369,000 | – | 685,704 | +100.0% | 0.35% | – |
Buy | FALCON MINERALS CORP | $11,144,000 | +38.1% | 3,537,707 | +6.9% | 0.34% | +39.7% | |
FTOCU | FTAC OLYMPUS ACQUISITION CORunit 08/24/2025 | $10,870,000 | +8.7% | 1,000,000 | 0.0% | 0.34% | +10.1% | |
DHX | Sell | DHI GROUP INC | $10,740,000 | -1.8% | 4,837,713 | -0.0% | 0.33% | -0.6% |
FTCVU | New | FINTECH ACQUISITION CORP Vunit 99/99/9999 | $10,670,000 | – | 1,000,000 | +100.0% | 0.33% | – |
IIIIU | New | INSU ACQUISITION CORP IIIunit 12/31/2026 | $10,570,000 | – | 1,000,000 | +100.0% | 0.33% | – |
YTRA | Sell | YATRA ONLINE INC | $10,259,000 | +157.1% | 5,315,350 | -0.1% | 0.32% | +160.7% |
ZGNX | New | ZOGENIX INC | $10,232,000 | – | 511,857 | +100.0% | 0.32% | – |
LINC | Sell | LINCOLN EDL SVCS CORP | $10,108,000 | -1.6% | 1,555,022 | -16.4% | 0.31% | -0.3% |
BMYRT | Sell | BRISTOL-MYERS SQUIBB COright 99/99/9999 | $10,078,000 | -71.0% | 14,602,975 | -5.4% | 0.31% | -70.6% |
RDI | Buy | READING INTL INCcl a | $9,959,000 | +62.7% | 1,983,928 | +4.4% | 0.31% | +65.2% |
SGMS | Sell | SCIENTIFIC GAMES CORP | $9,844,000 | -2.0% | 237,260 | -17.6% | 0.30% | -0.7% |
RMR | New | RMR GROUP INCcl a | $9,539,000 | – | 246,994 | +100.0% | 0.30% | – |
RFL | Sell | RAFAEL HLDGS INC | $9,080,000 | +29.1% | 389,370 | -14.2% | 0.28% | +30.7% |
NATR | Buy | NATURES SUNSHINE PRODS INC | $8,976,000 | +29.9% | 600,409 | +0.5% | 0.28% | +31.8% |
DARIOHEALTH CORP | $8,491,000 | -14.8% | 594,222 | 0.0% | 0.26% | -13.8% | ||
HCA | Sell | HCA HEALTHCARE INC | $8,440,000 | +31.6% | 51,317 | -0.3% | 0.26% | +33.7% |
PRCH | New | PORCH GROUP INC | $8,156,000 | – | 600,000 | +100.0% | 0.25% | – |
INAQW | New | INSU ACQUISITION CORP II*w exp 09/01/202 | $8,082,000 | – | 524,964 | +100.0% | 0.25% | – |
APEN | Buy | APOLLO ENDOSURGERY INC | $7,783,000 | +140.6% | 2,289,263 | +19.6% | 0.24% | +143.4% |
ARYA | ARYA SCIENCES ACQUISITION CO | $7,595,000 | +0.3% | 700,000 | 0.0% | 0.24% | +1.3% | |
SCPL | Sell | SCIPLAY CORPORATIONcl a | $7,065,000 | -46.7% | 510,122 | -37.6% | 0.22% | -45.9% |
SSKN | Sell | STRATA SKIN SCIENCES INC | $7,026,000 | +11.1% | 4,683,908 | -0.0% | 0.22% | +13.0% |
CDXS | New | CODEXIS INCcall | $6,549,000 | – | 300,000 | +100.0% | 0.20% | – |
VG | VONAGE HLDGS CORPcall | $6,438,000 | +25.9% | 500,000 | 0.0% | 0.20% | +27.6% | |
XELA | Sell | EXELA TECHNOLOGIES INC | $6,299,000 | +7.8% | 15,168,086 | -0.1% | 0.20% | +8.9% |
AFI | Buy | ARMSTRONG FLOORING INC | $6,217,000 | +15.8% | 1,627,441 | +4.6% | 0.19% | +17.7% |
GLMD | Sell | GALMED PHARMACEUTICALS LTD | $5,993,000 | -18.1% | 1,926,899 | -7.0% | 0.19% | -17.0% |
PAYAW | New | PAYA HOLDINGS INC*w exp 10/16/202 | $5,252,000 | – | 538,510 | +100.0% | 0.16% | – |
MACK | Sell | MERRIMACK PHARMACEUTICALS IN | $5,180,000 | +72.2% | 751,843 | -0.0% | 0.16% | +75.0% |
PRTY | PARTY CITY HOLDCO INC | $5,088,000 | +151.1% | 834,002 | 0.0% | 0.16% | +154.8% | |
ACET | Sell | ADICET BIO INC | $4,833,000 | -2.1% | 344,011 | -17.1% | 0.15% | -0.7% |
DVD | Sell | DOVER MOTORSPORTS INC | $4,302,000 | +60.9% | 1,895,337 | -0.0% | 0.13% | +62.2% |
CEREW | New | CEREVEL THERAPEUTICS HLDNG I*w exp 06/09/202 | $4,307,000 | – | 283,332 | +100.0% | 0.13% | – |
STRM | STREAMLINE HEALTH SOLUTIONS | $4,296,000 | 0.0% | 2,753,599 | 0.0% | 0.13% | +1.5% | |
SRL | Sell | SCULLY ROYALTY LTD | $3,728,000 | +0.7% | 753,159 | -0.1% | 0.12% | +2.7% |
CURIW | New | CURIOSITYSTREAM INC*w exp 10/14/202 | $2,762,000 | – | 200,000 | +100.0% | 0.09% | – |
ACER | Sell | ACER THERAPEUTICS INC | $2,593,000 | -9.1% | 989,755 | -0.1% | 0.08% | -8.0% |
SIGA | Sell | SIGA TECHNOLOGIES INC | $2,334,000 | -65.2% | 321,031 | -67.1% | 0.07% | -64.9% |
BCTG | BCTG ACQUISITION CORP | $2,288,000 | +10.4% | 200,000 | 0.0% | 0.07% | +12.7% | |
TSHA | Buy | TAYSHA GENE THERAPIES INC | $2,085,000 | +24.1% | 78,576 | +4.8% | 0.06% | +27.5% |
CYRN | CYREN LTD | $1,894,000 | -4.6% | 1,839,263 | 0.0% | 0.06% | -3.3% | |
HTGM | New | HTG MOLECULAR DIAGNOSTICS IN | $1,742,000 | – | 363,622 | +100.0% | 0.05% | – |
IMTXW | New | IMMATICS N.V*w exp 01/01/202 | $1,499,000 | – | 226,471 | +100.0% | 0.05% | – |
SFTTW | New | SHIFT TECHNOLOGIES INC*w exp 10/13/202 | $1,266,000 | – | 249,999 | +100.0% | 0.04% | – |
ALTGWS | ALTA EQUIPMENT GROUP INC*w exp 02/14/202 | $993,000 | +208.4% | 187,500 | 0.0% | 0.03% | +210.0% | |
AMCX | New | AMC NETWORKS INCcl a | $921,000 | – | 25,751 | +100.0% | 0.03% | – |
CVNA | New | CARVANA COcl a | $921,000 | – | 3,843 | +100.0% | 0.03% | – |
NK | Buy | NANTKWEST INC | $703,000 | +100.3% | 52,771 | +4.3% | 0.02% | +100.0% |
MOTS | Sell | MOTUS GI HLDGS INC | $394,000 | -3.4% | 415,501 | -0.5% | 0.01% | 0.0% |
FALCON MINERALS CORP*w exp 07/21/202 | $375,000 | +86.6% | 878,022 | 0.0% | 0.01% | +100.0% | ||
KTRA | New | KINTARA THERAPEUTICS INC | $349,000 | – | 272,969 | +100.0% | 0.01% | – |
MDIA | Buy | MEDIACO HLDG INCcl a | $270,000 | +3.8% | 103,680 | +4.8% | 0.01% | 0.0% |
ATXI | New | AVENUE THERAPEUTICS INC | $180,000 | – | 30,211 | +100.0% | 0.01% | – |
FTAC | Exit | FINTECH ACQUISITION CORP III | $0 | – | -22,978 | -100.0% | -0.01% | – |
NNBR | Exit | NN INC | $0 | – | -132,821 | -100.0% | -0.02% | – |
INSUW | Exit | INSURANCE ACQUISITION CORP*w exp 03/31/202 | $0 | – | -249,999 | -100.0% | -0.02% | – |
ENVA | Exit | ENOVA INTL INC | $0 | – | -48,363 | -100.0% | -0.02% | – |
SNSS | Exit | SUNESIS PHARMACEUTICALS INC | $0 | – | -691,651 | -100.0% | -0.03% | – |
ONDK | Exit | ON DECK CAP INC | $0 | – | -881,197 | -100.0% | -0.04% | – |
HTZGQ | Exit | HERTZ GLOBAL HLDGS INCcall | $0 | – | -1,300,000 | -100.0% | -0.04% | – |
HTGM | Exit | HTG MOLECULAR DIAGNOSTICS IN | $0 | – | -5,113,958 | -100.0% | -0.05% | – |
ONCT | Exit | ONCTERNAL THERAPEUTICS INC | $0 | – | -1,200,747 | -100.0% | -0.06% | – |
NEOS | Exit | NEOS THERAPEUTICS INC | $0 | – | -4,610,000 | -100.0% | -0.08% | – |
GRAY | Exit | GRAYBUG VISION INC | $0 | – | -250,000 | -100.0% | -0.10% | – |
DMAC | Exit | DIAMEDICA THERAPEUTICS INC | $0 | – | -756,193 | -100.0% | -0.10% | – |
ITCI | Exit | INTRA CELLULAR THERAPIES INC | $0 | – | -174,461 | -100.0% | -0.14% | – |
RCII | Exit | RENT A CTR INC NEW | $0 | – | -177,165 | -100.0% | -0.16% | – |
AMRS | Exit | AMYRIS INC | $0 | – | -2,531,191 | -100.0% | -0.23% | – |
ARYBU | Exit | ARYA SCIENCES ACQUISTION COunit 06/09/2027 | $0 | – | -850,000 | -100.0% | -0.29% | – |
FTACU | Exit | FINTECH ACQUISITION CORP IIIunit 12/01/2023 | $0 | – | -977,022 | -100.0% | -0.33% | – |
IWM | Exit | ISHARES TRrussell 2000 etf | $0 | – | -86,413 | -100.0% | -0.40% | – |
HAL | Exit | HALLIBURTON COcall | $0 | – | -1,086,200 | -100.0% | -0.40% | – |
INSU | Exit | INSURANCE ACQUISITION CORPcl a | $0 | – | -1,225,538 | -100.0% | -0.44% | – |
FRG | Exit | FRANCHISE GROUP INC | $0 | – | -598,334 | -100.0% | -0.46% | – |
INAQU | Exit | INSU ACQUISITION CORP IIunit 09/04/2025 | $0 | – | -1,575,000 | -100.0% | -0.50% | – |
PENN | Exit | PENN NATL GAMING INCput | $0 | – | -300,000 | -100.0% | -0.67% | – |
WRLD | Exit | WORLD ACCEP CORP DEL | $0 | – | -212,042 | -100.0% | -0.68% | – |
CAR | Exit | AVIS BUDGET GROUPput | $0 | – | -1,500,000 | -100.0% | -1.21% | – |
IWM | Exit | ISHARES TRcall | $0 | – | -700,000 | -100.0% | -3.21% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2021-02-16
About Nantahala Capital Management
Nantahala Capital Management is a hedge fund that was founded in 2004 by Wil Harkey. The firm is headquartered in Connecticut and has additional offices in New York and North Carolina. Nantahala Capital Management primarily invests in the technology, healthcare, and consumer sectors. The firm has a long-term investment approach and seeks to identify undervalued companies with strong growth potential.
Wil Harkey serves as the CEO and Chief Investment Officer of Nantahala Capital Management. He has over 20 years of experience in the finance industry and previously worked at Goldman Sachs and Maverick Capital. In addition to Harkey, the firm's leadership team includes COO and General Counsel, David Kozak, and CFO, Michael Kozak.
Nantahala Capital Management has a strong track record of generating positive returns for its investors. The firm's flagship fund, the Nantahala Fund, has delivered an annualized return of over 20% since its inception in 2006. The firm's success can be attributed to its disciplined investment approach and focus on long-term value creation.
Overall, Nantahala Capital Management is a well-respected hedge fund with a talented leadership team and a strong track record of performance. However, as with any investment, it is important for investors to conduct their own due diligence and carefully consider the risks before investing in the firm's funds.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Top long-term holdings
Name | Quarters owned | Latest quarter owned | Max weighting |
---|---|---|---|
ISHARES TR | 42 | Q3 2023 | 27.2% |
CODEXIS INC | 42 | Q3 2023 | 3.9% |
PATHWARD FINANCIAL INC | 35 | Q3 2023 | 6.3% |
SCIENTIFIC GAMES CORP | 34 | Q3 2022 | 5.3% |
DOVER MOTORSPORTS INC | 34 | Q3 2021 | 0.5% |
GOLDEN ENTMT INC | 33 | Q3 2023 | 2.1% |
QAD INC | 32 | Q3 2021 | 2.6% |
SCIENTIFIC GAMES CORP | 31 | Q4 2021 | 7.7% |
DOLBY LABORATORIES INC | 31 | Q4 2020 | 5.6% |
LINCOLN EDL SVCS CORP | 31 | Q4 2021 | 0.7% |
View Nantahala Capital Management's complete holdings history.
Latest significant ownerships (13-D/G)
Filed | Shares | Percentage | |
---|---|---|---|
AYTU BIOPHARMA, INC | June 16, 2023 | 1,086,812 | 19.7% |
Acer Therapeutics Inc. | February 14, 2023 | 1,226,191 | 7.5% |
Aeglea BioTherapeutics, Inc. | February 14, 2023 | 4,611,302 | 7.5% |
AKUMIN INC. | February 14, 2023 | 2,206,960 | 2.5% |
ALTA EQUIPMENT GROUP INC. | February 14, 2023 | 1,188,985 | 3.7% |
Apollo Endosurgery, Inc. | February 14, 2023 | 4,056,627 | 9.9% |
Autolus Therapeutics plc | February 14, 2023 | 7,782,018 | 4.7% |
Bioventus Inc. | February 14, 2023 | 3,168,574 | 5.1% |
CATALYST BIOSCIENCES, INC. | February 14, 2023 | 438,055 | 1.4% |
Drive Shack Inc. | February 14, 2023 | 6,500,000 | 7.0% |
View Nantahala Capital Management's complete significant-ownership history.
Latest filings
Type | Filed |
---|---|
4 | 2024-03-21 |
4 | 2024-03-15 |
SC 13G | 2024-03-11 |
13F-HR/A | 2024-02-15 |
13F-HR | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
SC 13G/A | 2024-02-14 |
View Nantahala Capital Management's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.